Clinical Characterization of Patients With Primary Biliary Cirrhosis Treated With Seladelpar in the Real-life Setting
NCT07549607 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-04-24
Summary
The seladelpar registry will collect real-world data of patients with PBC diagnosis treated with seladelpar in the real-life scenario in Germany and Switzerland.
Conditions
- Primary Bilary Cirrhosis (PBC)
Sponsors & Collaborators
-
University of Leipzig
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-01
- Primary Completion
- 2028-04-01
- Completion
- 2028-10-01
Countries
- Germany
- Switzerland
Study Locations
More Related Trials
-
Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC)
NCT02955602 ·Status: COMPLETED ·Phase: PHASE2
-
Monitoring the Response of Combination Ursodiol and Seladelpar Treatment
NCT07122206 ·Status: NOT_YET_RECRUITING
-
ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
NCT03602560 ·Status: COMPLETED ·Phase: PHASE3
-
Seladelpar in Adult Liver Transplant Recipients With Ischemic Cholangiopathy (SELIC).
NCT07305363 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSC
NCT04024813 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate Seladelpar in Subjects With Nonalcoholic Steatohepatitis (NASH)
NCT03551522 ·Status: TERMINATED ·Phase: PHASE2
-
Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients
NCT05292872 ·Status: COMPLETED
-
Study in Patients With Decompensated Liver Cirrhosis
NCT06380335 ·Status: ACTIVE_NOT_RECRUITING
-
A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness
NCT05014672 ·Status: COMPLETED ·Phase: PHASE2
-
The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
NCT02846896 ·Status: COMPLETED
-
A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCK
NCT06269484 ·Status: COMPLETED ·Phase: PHASE2
-
REpurposing SirolimUS in Compensated Advanced Chronic Liver Disease. the RESUS Proof of Concept Study
NCT05663944 ·Status: COMPLETED ·Phase: PHASE2
-
German SLD-Registry (Deutsches SLD-Register)
NCT04721665 ·Status: COMPLETED
-
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
NCT02932449 ·Status: COMPLETED
-
LEOPARD Training and Validation Data Collection Study
NCT06675604 ·Status: RECRUITING
-
Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)
NCT02247934 ·Status: COMPLETED
-
Ursodeoxycholic Acid in Patients With NAFLD - Clinical Observation
NCT05256979 ·Status: ACTIVE_NOT_RECRUITING
-
Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis
NCT02135536 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Immune Semaphorins in Steatotic Liver Disease and Sepsis
NCT06021743 ·Status: UNKNOWN
-
Study on Risk Factors and Prognosis of MASLD
NCT07433205 ·Status: COMPLETED
-
Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
NCT03053063 ·Status: TERMINATED ·Phase: PHASE3
-
Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASH
NCT05357248 ·Status: COMPLETED ·Phase: NA
-
Advanced Fibrosis Detection for MASLD in Primary Care
NCT07159386 ·Status: RECRUITING ·Phase: NA
-
The Referral to Hepatology Can be Improved Through an Electronic Medical Record (EMR)-Based Best Practice Alert (BPA) for an Appropriate Referral
NCT07580482 ·Status: COMPLETED ·Phase: NA
-
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
NCT05201404 ·Status: RECRUITING ·Phase: PHASE3